This is Osaka’s first heavy ion radiotherapy facility located in central Osaka City, where scanning beam irradiation is performed in all treatment rooms.

The Osaka Heavy Ion Therapy Center, located in central Osaka City, is the first heavy ion radiotherapy facility in Osaka. All three treatment rooms are equipped with scanning beam irradiation, which precisely delivers a narrow heavy ion beam extracted from an accelerator to “paint” the tumor.

To address tumor motion caused by respiration, a real-time tumor tracking irradiation system has been introduced, enabling more accurate treatment by minimizing positional deviations during irradiation.

Treatment Room 1 provides irradiation from horizontal and 45-degree angles, while Treatment Rooms 2 and 3 offer irradiation from horizontal and vertical directions. Real-time tumor tracking irradiation is available in Treatment Rooms 1 and 2.

Furthermore, the center collaborates with nearby institutions such as the Osaka International Cancer Institute and other designated cancer care hospitals to provide a comprehensive cancer treatment system.

For medical consultations, patients residing in Japan are required to have a referral from a medical institution. Overseas patients are generally required to be referred through medical tourism agencies affiliated with the center.

The Osaka Heavy Ion Therapy Center began treatment in October 2018 and has treated over 6,000 domestic and international patients as of the end of January 2026.

[Osaka Kansai International Medical Contribution Platform – Participating Medical Institutions]
https://j-medical-healthcare.com/osaka-advanced/

Location

〒540-0008
3-1-10 Otemae Chuo-ku Osaka City

Website

https://www.osaka-himak.or.jp/

Facility Overview

【site】　situated in the central of Osaka city, easy access and suitable for ambulatory.
【therapeutic instrument】　the compact size of heavy ion radiotherapy machine, high-speed scanning irradiation, synchrotron (17m in diameter, the world's smallest size) to the main accelerator of the accelerat
【facilities】 the universal design is offered safe and secure to the cancer patient 　

Specialty

heavy ion therapy for cancer

Available Programs

• Heavy Ion Therapy (Osaka)

  Heavy Ion Radiotherapy for Cancer
  Indications: Head and neck tumors, bone and soft tissue tumors, esophageal cancer, lung cancer, liver cancer, intrahepatic cholangiocarcinoma, pancreatic cancer, postoperative pelvic recurrence of colorectal cancer, kidney cancer, prostate cancer, cervical cancer, malignant melanoma in the gynecological field, and solitary metastases (lung, liver, or lymph nodes).

  Heavy Ion Radiotherapy for Cancer Indications: Head and neck tumors, bone and soft tissue tumors, esophageal cancer, lung cancer, liver cancer, intrahepatic cholangiocarcinoma, pancreatic cancer, postoperative pelvic recurrence of colorectal cancer, kidney cancer, prostate cancer, cervical cancer, malignant melanoma in the gynecological field, and solitary metastases (lung, liver, or lymph nodes). Please note that, as general eligibility criteria for heavy ion radiotherapy, patients must meet the following conditions: The lesion (cancer) is localized and not widespread The patient is able to remain in a resting supine position for approximately 30 minutes The target lesion is not adjacent to the gastrointestinal tract The patient’s general condition is good (Performance Status: 0–2; for bone and soft tissue tumors: 0–3) There are no active or refractory infections in the planned irradiation area The patient has been informed of the cancer diagnosis and wishes to undergo heavy ion radiotherapy of their own will Please note that the indication for heavy ion radiotherapy requires a comprehensive evaluation by specialists. After consultation, the case will be reviewed by a cancer board, and depending on the outcome, the patient may not be considered eligible for this treatment.

  View Details